查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1301153

灌注系统市场规模、份额和趋势分析报告：按应用、按地区、细分市场趋势，2023-2030 年

Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

灌注系统市场增长和趋势

预计到 2030 年，全球灌注系统市场规模将达到 15 亿美元。

此外，预计 2023 年至 2030 年该市场将以 4.7% 的复合年增长率增长。 慢性病的流行、器官移植的增加和多器官衰竭等因素预计将推动市场增长。 此外，对细胞研究的投资增加和生物製品製造的增加预计将进一步推动灌注系统行业的增长。

疫情上半年，灌注系统销量直线下降。 世界各国政府的封锁和限制导致去医院就诊的患者减少、手术减少以及研发活动放缓。 然而，随着政府和医务人员加大力度遏制病毒传播并为未来类似事件做好准备，预计市场将在 2021 年反弹并在预测期内达到峰值。

灌注系统市场报告亮点

  • 灌注系统市场按应用细分为心肺灌注系统、细胞灌注系统和离体器官灌注系统。 由于全球心脏病患病率较高，心肺灌注系统将在 2022 年占据市场主导地位
  • 按地区划分，2022 年北美市场份额最高。 慢性病的增加、医疗保健行业的成熟以及器官捐献者数量的增加正在推动该地区的市场增长。
  • COVID-19 大流行对灌注系统市场产生了重大负面影响。 医疗保健优先事项的转变、社会疏远和全球封锁等因素导致手术减少以及器官捐献和移植减少。
  • 冠状病毒大流行减少了灌注系统的销量，但在第一波大流行过去后，市场预计将在预测期内復苏并达到新冠疫情前的增长水平。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 调查方法
  • 信息获取
  • 信息或数据分析
  • 市场形成和验证
  • 型号详细信息
  • 辅助信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场前景
  • 分部展望
  • 竞争考虑因素

第 3 章灌注系统市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/辅助市场前景
  • 采用和增长前景图
  • 行业价值链分析
    • 报销框架
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
  • 灌注系统市场分析工具
    • 行业分析-波特分析
    • PESTEL 分析
    • 主要交易和战略联盟分析
    • 市场进入策略

第 4 章灌注系统：应用估算和趋势分析

  • 定义和范围
    • 心肺灌注系统
    • 细胞灌注系统
    • 离体器官灌注系统
  • 2021 年和 2030 年产品市场份额
  • 细分仪表板
  • 按应用划分的全球灌注系统市场前景
  • 2018-2030 年以下市场规模、预测和趋势分析
    • 心肺灌注系统
    • 细胞灌注系统
    • 体外灌注系统

第五章灌注系统市场：区域估计和趋势分析

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2022 年区域市场份额和主要参与者
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按因素进行 SWOT 分析（政治/法律、经济/技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场规模、预测、数量和趋势分析：
  • 北美
    • 2018-2030 年市场预估和预测（收入）
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 沙特阿拉伯
    • 南非
    • 阿拉伯联合酋长国

第 6 章竞争格局

  • 主要市场进入者的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要经销商和渠道合作伙伴名单
    • 主要客户
    • 2022 年主要参与者的市场份额分析
    • Getinge AB
    • Medtronic, plc.
    • LivaNova,.
    • Terumo Corporation
    • Nipro Corporation
    • XENIOS AG
    • Repligen Corporation
    • Spectrum Laboratories, Inc.
    • Merck KGaA.
    • Harvard Bioscience, Inc.
    • ALA Scientific Instruments, Inc.
    • Lifeline Scientific, Inc.
    • XVIVO Perfusion AB
Product Code: GVR-1-68038-470-3

Perfusion Systems Market Growth & Trends

The global perfusion systems market size is projected to reach USD 1.5 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.7% from 2023 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Perfusion Systems Market Report Highlights

  • Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2022 due to the high prevalence of cardiac diseases globally
  • In terms of region, North America accounted for the highest market share in 2022. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
  • The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
  • The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Technology
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Material outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Perfusion System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of cardiovascular and respiratory diseases
      • 3.4.1.2. Rising number of organ transplantations
      • 3.4.1.3. Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
      • 3.4.1.4. Government and NGO Initiatives to Encourage Organ Donation
      • 3.4.1.5. Increasing Investments in Cell - Based Research
      • 3.4.1.6. Increase in Biologic Manufacturing
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High Cost of Organ Transplantation
      • 3.4.2.2. Ethical Concerns and High Cost of Cell - Based Research
  • 3.5. Perfusion System Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Perfusion System: Application Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Cardiopulmonary Perfusion System
    • 4.1.2. Cell Perfusion System
    • 4.1.3. Ex - Vivo Organ Perfusion System
  • 4.2. Product Market Share, 2021 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Perfusion System Market by Application Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Cardiopulmonary Perfusion System
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. Oxygenators
      • 4.5.1.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Heart - Lung Machine
      • 4.5.1.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.4. Perfusion Pumps
      • 4.5.1.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.5. Cannula
      • 4.5.1.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.6. Monitoring System
      • 4.5.1.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.7. Others
      • 4.5.1.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Cell Perfusion System
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.2. Bioreactor Perfusion System
      • 4.5.2.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.3. Microfluidic Perfusion System
      • 4.5.2.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.4. Gravity/Pressure - driven Perfusion System
      • 4.5.2.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.5. Small Mammal Organ Perfusion System
      • 4.5.2.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Ex - vivo Perfusion System
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.2. Hypothermic Perfusion System
      • 4.5.3.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.3. Normothermic Perfusion System

Chapter 5. Perfusion System Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa
  • 5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 5.7. North America
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. U.S.
      • 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. Canada
      • 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Europe
    • 5.8.1. U.K.
      • 5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.2. Germany
      • 5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.3. France
      • 5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.4. Italy
      • 5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.5. Spain
      • 5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.6. Russia
      • 5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Asia Pacific
    • 5.9.1. China
      • 5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.2. Japan
      • 5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.3. India
      • 5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.4. Australia
      • 5.9.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.5. South Korea
      • 5.9.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.6. Singapore
      • 5.9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.10. Latin America
    • 5.10.1. Brazil
      • 5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.2. Mexico
      • 5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.3. Argentina
      • 5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.11. MEA
    • 5.11.1. Saudi Arabia
      • 5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.2. South Africa
      • 5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.3. UAE
      • 5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Getinge AB
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Medtronic, plc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. LivaNova,.
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Terumo Corporation
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Nipro Corporation
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. XENIOS AG
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Repligen Corporation
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Spectrum Laboratories, Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Merck KGaA.
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Harvard Bioscience, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. ALA Scientific Instruments, Inc.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. Lifeline Scientific, Inc.
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives
    • 6.3.16. XVIVO Perfusion AB
      • 6.3.16.1. Company overview
      • 6.3.16.2. Financial performance
      • 6.3.16.3. Product benchmarking
      • 6.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 5 Canada perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 6 Europe perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 7 Europe perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.K. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 10 France perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 11 Italy perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 12 Spain. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 13 APAC. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 14 APAC perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 15 China perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 16 Japan perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 17 India perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 18 Latin America. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 19 Latin America perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 20 Brazil. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 21 Mexico perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 22 Argentina. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 23 Middle East and Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 24 Middle East and Africa perfusion system market, by region, 2018 - 2030 (USD Million)
  • Table 25 South Africa. perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 26 Saudi Arabia perfusion system market, by application, 2018 - 2030 (USD Million)
  • Table 27 UAE. perfusion system market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value - chain - based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Perfusion System: market outlook
  • Fig. 14 Perfusion System competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Perfusion System market driver impact
  • Fig. 20 Perfusion System market restraint impact
  • Fig. 21 Perfusion System market strategic initiatives analysis
  • Fig. 22 Perfusion System market: application movement analysis
  • Fig. 23 Perfusion System market: application outlook and key takeaways
  • Fig. 24 Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 25 Cardiopulmonary Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 26 Oxygenators market estimates and forecast, 2018 - 2030
  • Fig. 27 Heart - Lung Machine market estimates and forecast, 2018 - 2030
  • Fig. 28 Perfusion Pumps market estimates and forecast, 2018 - 2030
  • Fig. 29 Cannula market estimates and forecast, 2018 - 2030
  • Fig. 30 Monitoring Systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Cell Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 33 Bioreactor Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 34 Microfluidic Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 35 Gravity/Pressure - driven Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 36 Small Mammal Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 37 Ex - Vivo Organ Perfusion System market estimates and forecast, 2018 - 2030
  • Fig. 38 Hypothermic market estimates and forecast, 2018 - 2030
  • Fig. 39 Normothermic market estimates and forecast, 2018 - 2030
  • Fig. 40 Global Perfusion System market: regional movement analysis
  • Fig. 41 Global Perfusion System market: regional outlook and key takeaways
  • Fig. 42 Global market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecast, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecast, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 62 U.K.
  • Fig. 63 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany market estimates and forecast, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France market estimates and forecast, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecast, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030
  • Fig. 72 Russia
  • Fig. 73 Russia market estimates and forecast, 2018 - 2030
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 76 China
  • Fig. 77 China market estimates and forecast, 2018 - 2030
  • Fig. 78 Japan
  • Fig. 79 Japan market estimates and forecast, 2018 - 2030
  • Fig. 80 India
  • Fig. 81 India market estimates and forecast, 2018 - 2030
  • Fig. 82 Thailand
  • Fig. 83 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecast, 2018 - 2030
  • Fig. 86 Australia
  • Fig. 87 Singapore market estimates and forecast, 2018 - 2030
  • Fig. 88 Latin America
  • Fig. 89 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 90 Brazil
  • Fig. 91 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 92 Mexico
  • Fig. 93 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 94 Argentina
  • Fig. 95 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 96 Middle East and Africa
  • Fig. 97 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 100 South Africa
  • Fig. 101 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 102 UAE
  • Fig. 103 UAE market estimates and forecast, 2018 - 2030
  • Fig. 104 Participant categorization - Perfusion System market
  • Fig. 105 Market share of key market players - Perfusion System market